Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis

Condition:   Immunoglobulin Light-chain Amyloidosis Interventions:   Drug: Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab;   Drug: Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab Sponsor:   Air Force Military Medical University, China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials